NHS England is on track to miss its key cancer treatment target by nearly 10,000 patients, raising fears that thousands of people, including those with bladder cancer, will face dangerous delays for life-saving surgery.
The Growing Gap in Cancer Care
The NHS set an interim target to treat 80% of cancer patients within 62 days of an urgent referral by March 2027. But the latest figures show the health service is falling short. In September 2026, only 70.7% of patients started treatment within that critical window, a drop from 71.9% in August. To get back on track, the NHS would need to treat about 24,400 patients on time each month. Instead, it is only managing roughly 21,500, creating a monthly shortfall of 2,850 patients. This means a cumulative gap of approximately 9,490 patients by the deadline next year.
Why Bladder Cancer Patients Are Especially Vulnerable
For patients with bladder cancer, the 62-day target is not just a number on a report; it is a crucial window that can mean the difference between a treatable disease and a fatal one. Bladder cancer often requires timely surgery to prevent the disease from progressing to a more advanced and incurable stage. When that window is missed, the cancer can grow or spread, significantly reducing a patient’s chances of survival. The human side of this is a story of families facing an agonizing wait, wondering if their loved one is running out of time while the system struggles to keep up.
Disparities and a Warning from Experts
The analysis of the figures reveals significant disparities in how different types of cancer are treated. While more than two-thirds of patients with prostate and breast cancers were treated within two months, the rates were much lower for other cancers. Only 60.9% of lung cancer patients and 60% of those with gynaecological cancers were treated on time. Head and neck cancers fared even worse, with barely half (56.5%) receiving timely care. This implies that bladder-cancer surgery waiting times may be disproportionately affected, as the system struggles to manage the overall backlog.
Prof Pat Price, the chair of Radiotherapy UK and a leading oncologist, issued a stark warning. “The government is going to miss its cancer treatment target because the NHS does not have enough staff or equipment to treat the number of patients coming through its doors,” she said. “This lack of leadership means thousands more people could die because they don’t get their treatment on time.” The shortfall, she explained, is a direct result of insufficient resources, leaving the human side of care to suffer behind the headlines.
What Patients Can Do Now
In the face of these delays, patients and their families can take action. If you have received an urgent referral for suspected cancer, it is important to stay in close contact with your healthcare team. Ask about your expected waiting time and what steps are being taken to expedite your care. For those awaiting bladder-cancer surgery, understanding the urgency of your situation is key. Speak to your doctor about your specific case and whether there are any alternative pathways or support services available. The system may be under strain, but your health is the priority, and being proactive can help ensure your voice is heard.
The failure to meet the 62-day target reflects broader leadership and resource failures within the NHS, according to experts. As the cumulative gap grows, the human cost becomes more apparent, with thousands of families left to face the uncertainty of delayed treatment. The next scheduled update on these figures will come in March 2027, when the full impact of the missed target will be clear.
Sources
- NHS England on track to miss key cancer treatment target by 10,000 patients
- NHS England
- Advice to patients in the West as Microsoft Outlook outage disrupts emails
- Health and care sector latest developments
- NHS England Removes Palantir Benefits Claim for 137 Trusts After Investigation: how 9 outlets framed it | NewsCord
- NHS rolls out groundbreaking immunotherapy for advanced anal cancer patients | National Health Executive
Photo: Harvy334 (CC0)
